A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)

Detalles Bibliográficos
Autores principales: Izzo, I, Albini, L, Calabresi, A, Motta, D, Bellagamba, R, Fezza, R, Narciso, P, Sighinolfi, L, Maggi, P, Focà, E, Mendeni, M, Manili, L, Magoni, M, Carosi, G, Quiros-Roldan, E, Torti, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113092/
http://dx.doi.org/10.1186/1758-2652-13-S4-P85
_version_ 1782205886064754688
author Izzo, I
Albini, L
Calabresi, A
Motta, D
Bellagamba, R
Fezza, R
Narciso, P
Sighinolfi, L
Maggi, P
Focà, E
Mendeni, M
Manili, L
Magoni, M
Carosi, G
Quiros-Roldan, E
Torti, C
author_facet Izzo, I
Albini, L
Calabresi, A
Motta, D
Bellagamba, R
Fezza, R
Narciso, P
Sighinolfi, L
Maggi, P
Focà, E
Mendeni, M
Manili, L
Magoni, M
Carosi, G
Quiros-Roldan, E
Torti, C
author_sort Izzo, I
collection PubMed
description
format Online
Article
Text
id pubmed-3113092
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130922011-06-13 A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial) Izzo, I Albini, L Calabresi, A Motta, D Bellagamba, R Fezza, R Narciso, P Sighinolfi, L Maggi, P Focà, E Mendeni, M Manili, L Magoni, M Carosi, G Quiros-Roldan, E Torti, C J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113092/ http://dx.doi.org/10.1186/1758-2652-13-S4-P85 Text en Copyright ©2010 Izzo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Izzo, I
Albini, L
Calabresi, A
Motta, D
Bellagamba, R
Fezza, R
Narciso, P
Sighinolfi, L
Maggi, P
Focà, E
Mendeni, M
Manili, L
Magoni, M
Carosi, G
Quiros-Roldan, E
Torti, C
A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title_full A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title_fullStr A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title_full_unstemmed A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title_short A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first-line HAART (the INCA trial)
title_sort magnifying glass onto renal function and serum lipid evolutions after tenofovir (tdf) and emtricitabine (ftc) in combination with atazanavir/ritonavir (atv/r) versus efavirenz (efv) as first-line haart (the inca trial)
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113092/
http://dx.doi.org/10.1186/1758-2652-13-S4-P85
work_keys_str_mv AT izzoi amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT albinil amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT calabresia amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT mottad amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT bellagambar amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT fezzar amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT narcisop amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT sighinolfil amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT maggip amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT focae amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT mendenim amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT manilil amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT magonim amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT carosig amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT quirosroldane amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT tortic amagnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT izzoi magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT albinil magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT calabresia magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT mottad magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT bellagambar magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT fezzar magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT narcisop magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT sighinolfil magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT maggip magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT focae magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT mendenim magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT manilil magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT magonim magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT carosig magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT quirosroldane magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial
AT tortic magnifyingglassontorenalfunctionandserumlipidevolutionsaftertenofovirtdfandemtricitabineftcincombinationwithatazanavirritonaviratvrversusefavirenzefvasfirstlinehaarttheincatrial

Ejemplares similares